ALEXANDRIA, Va., Oct. 8 -- United States Patent no. 12,435,145, issued on Oct. 7, was assigned to Five Prime Therapeutics Inc. (Thousand Oaks, Calif.).
"B7-H4 antibody formulations" was invented by Yong Quan (South San Francisco, Calif.), Chin-Yi Huang (South San Francisco, Calif.) and Harjeet Singh Ganda (South San Francisco, Calif.).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure provides pharmaceutical compositions comprising antibodies and antigen-binding fragments thereof that specifically bind to human B7-H4 (and optionally cynomolgus monkey, mouse, and/or rat B7-H4). The present disclosure also prides methods for treating disorders, such as cancer, by administering such pharmaceut...